Is BXP (BXP) Undervalued After Its Boston Dynamics Lease Win?

BXP (BXP) stock is back in focus after the company signed a long term lease with Boston Dynamics for about 320,000 square feet at Reservoir Place in Waltham, Massachusetts.

See our latest analysis for BXP.

BXP’s latest leasing wins with Boston Dynamics and McDermott Will & Schulte come as momentum in the stock has recently improved, with a 30 day share price return of 8.35% and a 90 day gain of 27.69%. However, the year to date share price is still down 3.17% and the 5 year total shareholder return sits at a loss of 26.66%.

If this kind of robotics and AI tenancy catches your interest, it may be worth widening your search using Simply Wall St’s screener for 31 robotics and automation stocks

With BXP trading at $65.67 and a stated intrinsic value implying around a 10% discount, plus only a modest gap to the average analyst price target, the key question is whether this reflects a mispricing or a market that is already accounting for potential future growth.

Most Popular Narrative: 4.9% Undervalued

The most followed narrative currently pegs BXP’s fair value at $69.05, slightly above the last close at $65.67. This puts the recent leasing headlines into a more measured context.

Occupancy and rent growth for BXP's high quality, centrally located assets and premier developments are set to benefit from a marked return to in person work mandates and a strong "flight to quality", as demonstrated by significant tenant demand, tightening vacancies in NYC and Boston, and double digit increases in asking rents in premier submarkets, supporting higher future revenues and NOI per square foot.

Read the complete narrative.

Curious what underpins that valuation gap for BXP? The narrative references measured revenue growth, steady earnings progress, and a forward earnings multiple that sits above the wider office REIT group. The key point is how those elements are combined over time to arrive at that single fair value number.

Result: Fair Value of $69.05 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still real pressure points for BXP, including softer life science and office demand in key markets, as well as the capital intensity of projects like 343 Madison.

Find out about the key risks to this BXP narrative.

Next Steps

If the mix of risks and rewards around BXP feels finely balanced, now is a good time to review the details yourself and pressure test the assumptions. To weigh both sides in one place, start with our breakdown of 2 key rewards and 4 important warning signs

Looking for more investment ideas beyond BXP?

If you want to build on what you have learned from BXP and avoid missing other opportunities, now is the moment to scan the market for fresh ideas.

• Target potential income pillars by reviewing companies in the 9 dividend fortresses that may suit a portfolio built around regular cash returns.
• Hunt for attractively priced opportunities using the 43 high quality undervalued stocks to spot stocks where current prices differ from underlying fundamentals.
• Focus on stability and resilience by checking the 67 resilient stocks with low risk scores and see which companies align with a lower risk profile.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com